Mpox

Mpox is an exotic infectious disease caused by the Mpox virus. The disease was first identified in laboratory monkeys, thus earning its name, but in its natural state, it seems to infect rodents more than primates. A fever, headache, muscle pains, swollen lymph nodes, and fatigue are the first symptoms in humans. After this, a rash forms with blisters and crusts. Symptoms typically appear 7 to 14 days after exposure. In most cases, symptoms last 2 to 4 weeks. Children, pregnant women, and people with suppressed immune systems are at greater risk of severe cases.

Human Monkeypox – Epidemiology, Clinical Characteristics, Diagnosis, and Prevention

The human monkeypox virus, which belongs to the genus Orthopoxvirus of the family Poxviridae, is a DNA virus.

What is Monkeypox?

Monkeypox Epidemiology

Monkeypox 2003 U.S. Outbreak

Monkeypox; What is It and How Do We Treat It?

Latest Mpox News and Research

Unraveling the architecture of poxvirus cores

A recent re-emergence and outbreak of Mpox brought poxviruses back as a public health threat, underlining an important knowledge gap at their core.

6 Feb 2024

UKHSA unveils groundbreaking Pathogen Genomics Strategy for pandemic preparedness

The UK Health Security Agency (UKHSA) has today published its Pathogen Genomics Strategy, laying out a 5 year plan for the organization's role in the wider delivery of pathogen genomics to prepare for and respond to infectious disease threats to public health.

24 Jan 2024

Combined vaccination and behavior change efforts averted 64% of US mpox cases, study reveals

The effectiveness of the combination of current preventive responses against monkeypox (Mpox).

10 Jan 2024

Global study reveals varied intention to receive monkeypox vaccine: 61% prevalence worldwide

The global prevalence and regional differences in the intention to receive the monkeypox.

4 Jan 2024

Smaller mpox vaccine doses and intradermal delivery elicit detectable immune response, study shows

Delivering the two-dose mpox vaccine, called JYNNEOS, in smaller than the usual FDA-approved doses, and by injection between layers of the skin rather than by the standard route under the skin, produced a detectable immune response, a new study shows.

13 Dec 2023

Pediatric viral threats surge in the 21st century: A call for One Health approach

Scoping review in "Pediatric Research" examines the rise of pediatric viral diseases in the 21st century and underscores the importance of a One Health approach, integrating human, animal, and ecosystem health, to combat these emerging and re-emerging infectious threats effectively.

9 Nov 2023

Lab-grown skin organoids help scientists understand monkeypox infection

Skin organoids offer a powerful platform for drug discovery in the ongoing fight against the virus formerly known as monkeypox.

16 Oct 2023

Healthcare settings and mpox transmission: Understanding the risk factors

The stability of the monkeypox (Mpox) virus in various surroundings and bodily fluid.

12 Oct 2023

KFF Health News' 'What the Health?': An encore: 3 HHS secretaries reveal what the job is really like

This week, while KFF Health News' "What the Health?" takes a break, here’s an encore of a favorite episode this year: Host and chief Washington correspondent Julie Rovner leads a rare conversation with the current and two former secretaries of Health and Human Services.

5 Oct 2023

Monkeypox mimics smallpox vaccine's immune response, new study reveals

The study in Nature Communications reveals that MPOX infection triggers an anti-viral antibody response akin to that from smallpox vaccination. Utilizing a comprehensive array of ELISAs, scientists found a high level of specificity and sensitivity in detecting antibodies against both MPOX and smallpox, offering a new, accurate way to measure immune responses.

26 Sep 2023

Scientists develop Australia’s first-of-its-kind next-gen mpox diagnostic tool

In a collaborative study published in The Lancet Microbe, the team of scientists, led by the Peter Doherty Institute for Infection and Immunity (Doherty Institute) and WEHI (Walter and Eliza Hall Institute of Medical Research), revealed MPXV-CRISPR – a powerful diagnostic tool capable of detecting MPXV in clinical samples with acute precision and at a faster rate than any other method, thanks to the power of CRISPR technology.

20 Sep 2023

Game-changing point-of-care assay could revolutionize Mpox detection worldwide

Researchers developed a point-of-care assay for the rapid detection of mpox virus.

20 Sep 2023

Study assesses duration of protection offered by smallpox infection and possible cross-reaction with Mpox virus

More than 43 years ago, many Chinese residents were vaccinated with the vaccinia virus Tiantan strain (VTT) to protect them from smallpox infection.

19 Sep 2023

Imported case of monkeypox leads to local transmission in China

Monkeypox (mpox) is a zoonotic disease caused by the mpox virus (MPXV) that has been primarily limited to Central and West African nations since its discovery.

15 Sep 2023

Novel amino acid mutations suggest local monkeypox transmission in Guangzhou, China

The monkeypox (mpox) virus has caused worldwide transmission since its initial report in England in early May 2022.

15 Sep 2023

Study shows how sexual behaviors change with age

A new study published today shows the number of sexual partners we have changes as we age – and there are some surprising results.

8 Sep 2023

Global case series uncovers Mpox resurgence among previously infected or fully vaccinated individuals

Researchers elucidated monkeypox's (mpox) epidemiological and clinical features.

8 Sep 2023

Vaccination reduces risk of severe COVID-19 in solid organ transplant recipients

Findings from a two-year study of nearly 2,400 solid organ transplant recipients, conducted by the Johns Hopkins Transplant Research Center (TRC) in collaboration with the New York University Center for Surgical and Applied Transplant Research, indicate spikes of post-vaccination SARS-CoV-2 viral infections (commonly known as COVID-19 breakthrough cases) remain common, yet hospitalization rates have dramatically dropped following the first wave of the virus' omicron subvariant.

18 Aug 2023

Human challenge trials: A game-changer in vaccine development? Examining their role in shaping the pandemic response

The history of using human challenge trials in developing vaccines.

15 Aug 2023

UKHSA unveils world-leading Vaccine Development and Evaluation Centre

The UK Health Security Agency (UKHSA) has today unveiled its world-leading Vaccine Development and Evaluation Centre (VDEC), which is building on its pandemic legacy and helping develop life-saving new vaccines for the UK and worldwide.

7 Aug 2023

Mpox

Overview

What is Monkeypox?

Monkeypox Epidemiology

Monkeypox 2003 U.S. Outbreak

Feature Articles

Monkeypox; What is It and How Do We Treat It?

Latest Mpox News and Research

Unraveling the architecture of poxvirus cores

UKHSA unveils groundbreaking Pathogen Genomics Strategy for pandemic preparedness

Combined vaccination and behavior change efforts averted 64% of US mpox cases, study reveals

Global study reveals varied intention to receive monkeypox vaccine: 61% prevalence worldwide

Smaller mpox vaccine doses and intradermal delivery elicit detectable immune response, study shows

Pediatric viral threats surge in the 21st century: A call for One Health approach

Lab-grown skin organoids help scientists understand monkeypox infection

Healthcare settings and mpox transmission: Understanding the risk factors

KFF Health News' 'What the Health?': An encore: 3 HHS secretaries reveal what the job is really like

Monkeypox mimics smallpox vaccine's immune response, new study reveals

Scientists develop Australia’s first-of-its-kind next-gen mpox diagnostic tool

Game-changing point-of-care assay could revolutionize Mpox detection worldwide

Study assesses duration of protection offered by smallpox infection and possible cross-reaction with Mpox virus

Imported case of monkeypox leads to local transmission in China

Novel amino acid mutations suggest local monkeypox transmission in Guangzhou, China

Study shows how sexual behaviors change with age

Global case series uncovers Mpox resurgence among previously infected or fully vaccinated individuals

Vaccination reduces risk of severe COVID-19 in solid organ transplant recipients

Human challenge trials: A game-changer in vaccine development? Examining their role in shaping the pandemic response

UKHSA unveils world-leading Vaccine Development and Evaluation Centre

How do mass spectrometry and omics impact neurosciences?

Meet Dr. Chao Ma: Pioneering 'Leukemia-on-a-Chip' for CAR T Cell Therapy at SLAS 2024

RNA Therapies in Liver Disease: Insights from Ochre Bio's CEO

Mpox

Overview

Feature Articles

Monkeypox; What is It and How Do We Treat It?

Latest Mpox News and Research

How do mass spectrometry and omics impact neurosciences?

Meet Dr. Chao Ma: Pioneering 'Leukemia-on-a-Chip' for CAR T Cell Therapy at SLAS 2024

RNA Therapies in Liver Disease: Insights from Ochre Bio's CEO

Newsletters you may be interested in